Clinical Trial Update: Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating how starch digestibility affects cardio-metabolic and inflammatory parameters in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mondelēz International, Inc. | Conditions: Type2 Diabetes | NA | Status: COMPLETED